The rising popularity in GLP-1 agonists for diabetes has led to a debate about application forms : skin-applied devices versus capsules. Traditionally , GLP-1 therapies were only available in tablet https://poppyvnlk001232.aioblogs.com/93682896/glp-1-transdermal-delivery-systems-vs-oral-medications-which-suitable-for-you